Intrinsic Value of S&P & Nasdaq Contact Us

Teva Pharmaceutical Industries Limited TEVA NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • IL • USD

SharesGrow Score
53/100
3/7 Pass
SharesGrow Intrinsic Value
$51.42
+61.9%
Analyst Price Target
$38.33
+20.6%

There have been 50 recent insider transactions recorded for Teva Pharmaceutical Industries Limited (TEVA), including 9 buys and 40 sells. Total insider buying was valued at $20.99K and total insider selling at $28.49M.

Notable insiders with recent activity include Sabag Mark, Francis Richard D, Daniell Richard. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — TEVA

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-03-17 Sabag Mark See "remarks" Informative Sell 62,102 $30.14 $1.87M 224,940
2026-03-05 Francis Richard D President and CEO Option Exercise (Sell) 42,452 - - 127,359
2026-03-05 Sabag Mark See "remarks" Option Exercise (Sell) 15,723 - - 47,170
2026-03-05 Daniell Richard EVP, Europe Commercial Option Exercise (Sell) 17,295 - - 51,887
2026-03-05 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option Exercise (Sell) 19,916 - - 59,748
2026-03-05 Weiss Amir Chief Accounting Officer Option Exercise (Sell) 3,537 - - 10,613
2026-03-05 Hughes Eric A See "remarks" Option Exercise (Sell) 19,654 - - 58,962
2026-03-05 Fox Christine EVP, U.s. Commercial Option Exercise (Sell) 17,819 - - 53,459
2026-03-05 Shields Matthew EVP, Global Operations Informative Sell 17,295 $31.67 $547.7K 9,989
2026-03-05 Jover Placid See "remarks" Informative Sell 14,150 $31.67 $448.11K 6,774
2026-03-05 Savage Brian Interim Chief Legal Officer Option Exercise (Sell) 3,580 - - 10,740
2026-03-04 Francis Richard D President and CEO Option Exercise (Sell) 50,223 - - 100,446
2026-03-04 Sabag Mark See "remarks" Option Exercise (Sell) 33,512 - - -
2026-03-04 Daniell Richard EVP, Europe Commercial Option Exercise (Sell) 33,512 - - -
2026-03-04 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option Exercise (Sell) 33,512 - - -
2026-03-04 Weiss Amir Chief Accounting Officer Option Exercise (Sell) 10,679 - - -
2026-03-04 Hughes Eric A See "remarks" Option Exercise (Sell) 23,251 - - 46,503
2026-03-04 Fox Christine EVP, U.s. Commercial Option Exercise (Sell) 20,461 - - 40,923
2026-03-04 Shields Matthew EVP, Global Operations RSU Award 33,424 - - 33,424
2026-03-04 Jover Placid See "remarks" RSU Award 37,982 - - 37,982
2026-03-04 Lippman Evan EVP, Business Development RSU Award 27,347 - - 27,347
2026-03-04 Savage Brian Interim Chief Legal Officer Option Exercise (Sell) 4,744 - - -
2026-03-03 Francis Richard D President and CEO Option Exercise (Sell) 891,315 - - -
2026-03-03 Sabag Mark See "remarks" Option Exercise (Sell) 141,478 - - -
2026-03-03 Daniell Richard EVP, Europe Commercial Option Exercise (Sell) 141,478 - - -
2026-03-03 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option Exercise (Sell) 141,478 - - -
2026-03-03 Weiss Amir Chief Accounting Officer Option Exercise (Sell) 5,179 - - 5,180
2026-03-03 Hughes Eric A See "remarks" Option Exercise (Sell) 141,478 - - -
2026-03-03 Savage Brian Interim Chief Legal Officer Informative Sell 1,274 $32.36 $41.23K 2,926
2026-02-26 Kalif Eliyahu Sharon EVP, Chief Financial Officer Informative Sell 345,810 $33.64 $11.63M 57,478
2026-02-15 Francis Richard D President and CEO Option Exercise (Sell) 620,110 - - -
2026-02-11 Savage Brian Interim Chief Legal Officer Unknown 4,503 $34.70 $156.25K -
2026-01-27 Francis Richard D President and CEO RSU Award 620,110 - - 620,110
2026-01-27 Sabag Mark See "remarks" RSU Award 141,478 - - 141,478
2026-01-27 Daniell Richard Exec. VP, European Commercial RSU Award 141,478 - - 141,478
2026-01-27 Kalif Eliyahu Sharon EVP, Chief Financial Officer RSU Award 141,478 - - 141,478
2026-01-27 Hughes Eric A See "remarks" RSU Award 141,478 - - 141,478
2025-12-16 Mignone Roberto Director Informative Sell 77,400 $30.24 $2.34M 367,600
2025-12-16 Weiss Amir Chief Accounting Officer Informative Sell 12,300 $30.20 $371.5K 5,650
2025-12-09 Sabag Mark See "remarks" Option Exercise (Sell) 118,724 $18.61 $2.21M -
2025-12-09 Daniell Richard Exec. VP, European Commercial Option Exercise (Sell) 15,011 $16.99 $255.04K -
2025-12-02 Lichtenstein Chen Director Option Exercise (Sell) 4,804 - - -
2025-11-26 Mignone Roberto Director Informative Sell 50,000 $26.03 $1.3M 445,000
2025-11-20 Fox Christine EVP, Head of U.s. Commercial Informative Sell 28,229 $24.78 $699.52K 63,647
2025-11-14 Fox Christine EVP, Head of U.s. Commercial Informative Sell 30,000 $25.11 $753.32K 28,384
2025-11-06 Mignone Roberto Director Informative Sell 200,000 $24.11 $4.82M 495,000
2025-11-06 Weiss Amir Chief Accounting Officer Informative Sell 12,300 $24.44 $300.56K 17,950
2025-09-05 Mcavoy David R. EVP, Chief Legal Officer Informative Buy 1,113 $18.86 $20.99K 13,027
2025-08-01 Hughes Eric A See "remarks" Informative Sell 52,742 $15.16 $799.44K -
2025-08-01 Jover Placid See "remarks" Informative Sell 6,053 $15.16 $91.75K 6,774
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message